 LAS VEGAS, NV ACCESSWIRE April 22, 2021 CLS Holdings USA, Inc. OTCQB:CLSHCSE:CLSH, the Company or CLS, a diversified cannabis company operating as Cannabis Life Sciences, today announced that it has amended the terms of 6,229,672 in principal amount, which includes capitalized interest, of its outstanding unsecured convertible debentures the U.S. Debentures issued October 25, 2018 and October 31, 2018 by, among other things, i reducing the conversion price from 0.80 per unit to 0.30 per unit; and ii extending the maturity date of the U.S. Debentures by one year to four 4 years from the execution date of the U.S. Debentures. The exercise price of the warrants issuable upon conversion of the U.S. Debentures remains unchanged. 